Serina Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Serina Therapeutics, Inc. (SER) reported Earnings Per Share, Basic and Diluted of -$0.23 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-29
- Serina Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was $0.06, a 10.97% decline year-over-year.
- Serina Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.05.
- Serina Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.07.
- Serina Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.06.
- Serina Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.23.
- Serina Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.29.
- Serina Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.33.
- Serina Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.21.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.06 derived: net income ÷ weighted average shares · filed 2022-03-29 | $0.11 derived: net income ÷ weighted average shares · filed 2022-11-10 | $0.17 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.23 10-K · filed 2022-03-29 |
| 2021-09-30 | -$0.05 10-Q · filed 2021-11-12 | $0.12 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.17 10-Q · filed 2021-11-12 | $0.23 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-06-30 | -$0.07 10-Q · filed 2021-08-13 | -$0.12 10-Q · filed 2021-08-13 | $0.18 derived: net income ÷ weighted average shares · filed 2022-08-12 | |
| 2021-03-31 | -$0.06 10-Q · filed 2021-05-17 | $0.12 derived: net income ÷ weighted average shares · filed 2022-05-13 | ||
| 2020-12-31 | $0.06 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$0.29 10-K · filed 2022-03-29 | ||
| 2020-09-30 | -$0.07 10-Q · filed 2021-11-12 | -$0.22 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$0.07 10-Q · filed 2021-08-13 | -$0.16 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$0.08 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | -$0.33 10-K · filed 2021-03-31 | |||
| 2019-09-30 | -$0.09 10-Q · filed 2020-11-16 | -$0.25 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | -$0.08 10-Q · filed 2020-08-14 | -$0.17 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | -$0.09 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | -$0.21 10-K/A · filed 2020-03-31 | |||
| 2018-09-30 | -$0.06 10-Q · filed 2019-11-14 | -$0.12 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | -$0.06 10-Q · filed 2019-08-14 | -$0.06 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | -$0.01 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | -$0.21 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |